Stock screener

IMMX

Conviction 96HealthcareScan · Thu, Sep 24, 2026
Hammer

Immix Biopharma, Inc. (IMMX) closed at $11.71 (-1.80%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is above its 50-day and above its 200-day moving average. RSI(14) 43, RS Rating 99, -19.1% from its 52-week high, +115.6% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

IMMX$11.71-1.80%
ResistanceSupportVol 14
63 bars
Vol MA14 1.54M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Immix Biopharma, Inc.PHARMACEUTICAL PREPARATIONSwww.immixbio.com ↗
Price11.71
Change-1.80%
Gap-0.34%
Rel volume1.82×
Avg volume1.47M
Avg $ vol18.87M
SMA 2012.94
SMA 5011.47
SMA 2009.03
Price vs 50+2.02%
Price vs 200+29.60%
MA stackbullish
50/200 cross—
Supertrendup · 11.61
RSI (14)43
MACD hist-0.22
MACD cross—
Stoch %K / %D18 / 23
ADX (14)20
+DI / −DI16 / 23
RSI divergence—
MACD divergence—
ATR %6.80%
ADR %5.90%
52w high14.47
52w low2.04
From 52w high-19.11%
Above 52w low+473.77%
New 52w highNo
SqueezeOff
Bollinger width26.25%
%B0.14
Donchian pos15.18%
Donchian high14.61
Donchian low11.19
AVWAP (52w high)13.07
vs AVWAP high-10.44%
AVWAP (52w low)8.59
vs AVWAP low+36.21%
OBV trendDown
Chaikin MF (20)0.03
Today vs 20d1.82×
Avg vol (14d)1.54M
Avg vol (20d)1.47M
Avg $ vol (20d)18.87M
Market cap837.37M
RS Rating99 / 99
RS 3m (vs SPY)+15.93%
RS 6m (vs SPY)+14.55%
RS line new highNo
Trend template8/8
Technical rank71.9
1 week-7.98%
1 month-19.11%
3 months+20.42%
6 months+31.37%
1 year+470.98%
YTD+115.56%
P/E-28.44
P/B3.66
P/S41.87
P/FCF-33.95
EPS-0.8900
Div yield—
ROE-12.86%
ROA-12.31%
Debt/Eq—
Current25.13
EV/EBITDA—
Gross margin—
Net margin-147.19%
Rev growth—
EPS growth-36.21%
Price target23.40
Target upside99.91%
Analyst ratingBuy
Institutional86.85%
Ent. value611.88M
Revenue20M
Net income-11.56M
Gross profit—
Free cash flow-24.66M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out54.41M
Employees21
ListedThu, Dec 16, 2021
Free float31.78M
Float %60.0%
Short interest9.62M
Days to cover5.9d
Short volume49.1%
Squeeze score83 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.18 vs −$0.17
Last surprise-5.9% miss
Setup gradeA+
Conviction96 / 100
Pattern quality—
Tech rank71.9 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMMX

All disclosures →
No recent disclosed trades by Congress in IMMX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMMX

InsiderSideShares
Adams Helen C.
Director · Common Stock · 2026-05-22
Grant6.25K
Chudnovsky Yekaterina
Director · Common Stock · 2026-05-22
Grant6.25K
Ng Carey
Director · Common Stock · 2026-05-22
Other—
Hsu Jason
Director · Stock Option (Right to Buy) · 2026-05-22
Grant12.5K
Marquet Magda
Director · Stock Option (Right to Buy) · 2026-05-22
Grant12.5K
BUCHAN JANE
Director · Stock Option (Right to Buy) · 2026-05-22
Grant12.5K
CHANG NANCY T
Director · Common Stock · 2026-05-22
Other—
Hsu Jason
Director · Common Stock · 2026-05-22
Other—
Hsu Jason
Director · Common Stock · 2026-05-22
Grant6.25K
Rachman Ilya M
CEO and Chairman · Stock Option (Right to Buy) · 2026-05-22
Grant500K

SEC filings

EDGAR filings in IMMX · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.